According to IMARC Group’s latest report, titled “Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global wound care biologics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 8% during 2021-2026. Wound care biologics refer to active biological agents that facilitate the re-establishment of repair mechanisms in the intracellular, intercellular and extracellular materials of the body. They include biological skin substitutes and topical agents consisting of plant-derived active biomolecules that exhibit anti-inflammatory or antioxidant properties. Wound care biologics are widely used for treating burns, surgical and traumatic wounds, diabetic foot and venous and pressure ulcers. They aid in reducing the risks of infections, pain, swelling, joint damage and skin diseases. They are widely used across hospitals, ambulatory surgery centers (ASCs), burn centers and wound clinics.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.
Request for a free sample copy of this report: https://www.imarcgroup.com/wound-care-biologics-market/requestsample
Market Trends and Drivers:
The global wound care biologics market is primarily being driven by the rising incidence of burn injuries and accidents resulting in chronic wounds. Moreover, the rising geriatric population, which is more susceptible to various medical ailments, is favoring the market growth. Various technological advancements, such as the introduction of ultrasonic probes and negative pressure wound therapy (NPWT) devices, are providing a thrust to the market growth. In line with this, the implementation of various government initiatives promoting public health and the increasing prevalence of chronic ailments are anticipated to positively impact the market growth.
Wound Care Biologics Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the wound care biologics market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Smith & Nephew
- Molnlycke Health Care
- Integra lifesciences
- Osiris Therapeutics
- Nuo Therapeutics
- Wright Medical
- Mimedx Group
- Solsys Medical
- Avita Medical
- ConvaTec Group
- Cytori Therapeutics
- Johnson & Johnson
- Leap Therapeutics
Key Market Segmentation:
The report has segmented the global wound care biologics market on the basis of product, wound type, application, end-user and region.
- Market Breakup by Product:
- Biologic Skin Substitutes
- Human Donor Tissue-Derived Products
- Acellular Animal -Derived Products
- Biosynthetic Products
- Topical Agents
- Biologic Skin Substitutes
- Market Breakup by Wound Type:
- Diabetic Foot Ulcers
- Venous Ulcers
- Pressure Ulcers
- Surgical and Traumatic Wounds
- Market Breakup by Application:
- Acute Wound
- Chronic Wound
- Surgical Wound
- Market Breakup by End-User:
- Burn Centres and Wound Clinics
- Market Breakup by Region:
- Asia Pacific
- North America
- Middle East and Africa
- Latin America
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/wound-care-biologics-market
Key Highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800